Skip to main content

Table 6 Wipe sample extraction recoveries (accuracy)

From: Accessible analytical methodology for assessing workplace contamination of antineoplastic drugs in limited-resource oncology health-care settings

Antineoplastic drug

Type of sample

Recovery interval (%)

Mean recovery and (RSD) (%)

Ifosfamide

LCS

90.5–111.8

98.8 (5.6)

 

PQC

85.2–115.0

95.7 (8.1)

 

PQC + SPE

80.3–107.9

96.2 (10.9)

Cyclophosphamide

LCS

93.0–104.6

98.5 (7.9)

 

PQC

91.9–106.7

94.9 (8.5)

 

PQC + SPE

87.3–103.8

93.5 (12.8)

Paclitaxel

LCS

89.3–115.6

108.2 (10.1)

 

PQC

83.4–108.8

92.7 (9.8)

 

PQC + SPE

79.8–113.0

88.7 (7.3)

  1. LCS laboratory control sample, PQC performance quality control sample, SPE solid-phase extraction, RSD relative standard deviation